(1)
Scrivo, R.; Diamanti, A. P.; Chimenti, M. S.; Molteni, E.; Sciarra, G.; Bari, F.; Greco, E.; Bergamini, A.; Laganà, B.; Conti, F. Secukinumab Treatment in Patients With Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome. acmcr 2022, 6, 660-668.